C. glabrata FKS2/CAGL0K04037g Literature Guide


Literature
Other names in use for C. glabrata FKS2: CAGL-IPF2142, CAGL-CDS0043.1, CAG61362.1, GVI51_K03883, CAGL0K04037g

FKS2 LITERATURE TOPICS

Proteome-wide Analysis
Virulence-related
Other Topics
Regulation
Related Species
Candida tropicalis
Related Genes/Proteins
Genetics/Cell Biology
 Ploidy
Curated Literature
 Alias
Gene Product Information
Research Aids and Literature
Disease
Genome-wide Analysis
Nucleic Acid Information
Life Cycle

FKS2 - Candida tropicalis

ReferenceSpeciesOther Genes Addressed
Arendrup MC, et al. (2023) European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study. J Infect
CGD Papers Entry Pubmed Entry
C. albicans |GSC1 |GSL1 |ITS1 |ITS2
C. glabrata |FKS1 |ITS1 |ITS2
C. parapsilosis |FKS1 |ITS1 |ITS2
C. dubliniensis |ITS1 |ITS2
Czajka KM, et al. (2023) Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells 12(22)
CGD Papers Entry Pubmed Entry
C. auris |CDR1 |CDR2 |ERG11 |FKS1 |MDR1 |MRR1 |SNQ2
C. albicans |ALS3 |BGL2 |CDR1 |CDR2 |DDR48 |ERG11 |ERG25 |ERG3 |ERG5 |ERG6 |FCY2 |FCY21 |FUR1 |FZO1 |MORE
C. glabrata |CDR1 |ERG11 |FCY1 |FCY2 |FKS1 |FUR1 |PDH1 |PDR1 |PDR16 |SNQ2
Szekely J, et al. (2023) Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak. Epidemiol Infect 151:e146
CGD Papers Entry Pubmed Entry
C. albicans |GSC1 |GSL1
C. glabrata |FKS1
C. parapsilosis |FKS1
Diaz-Garcia J, et al. (2021) Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates. Antimicrob Agents Chemother 65(12):e0124921
CGD Papers Entry Pubmed Entry
C. glabrata |ERG11 |FKS1
C. albicans |ERG11 |GSC1 |GSL1
Lim HJ, et al. (2020) Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species. Antimicrob Agents Chemother 64(11)
CGD Papers Entry Pubmed Entry
C. glabrata |FKS1 |PDR1
C. albicans |ERG11 |GSC1 |GSL1
C. parapsilosis |ERG11
Shaw KJ and Ibrahim AS (2020) Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. J Fungi (Basel) 6(4)
CGD Papers Entry Pubmed Entry
C. dubliniensis |GWT1
C. parapsilosis |GWT1
C. glabrata |FKS1 |GWT1 |PDR1
C. albicans |CDR11 |GWT1 |SNQ2
Sakagami T, et al. (2019) Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital. J Infect Chemother 25(1):34-40
CGD Papers Entry Pubmed Entry
C. glabrata |FKS1
C. albicans |GSC1 |GSL1 |GSL2
Xiao M, et al. (2018) Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms. Infect Drug Resist 11:155-161
CGD Papers Entry Pubmed Entry
C. glabrata |FKS1
Pfaller MA, et al. (2015) Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012). J Antibiot (Tokyo) 68(9):556-61
CGD Papers Entry Pubmed Entry
C. glabrata |FKS1
Castanheira M, et al. (2014) Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents 44(4):320-6
CGD Papers Entry Pubmed Entry Reference LINKOUT
C. glabrata |FKS1
Castanheira M, et al. (2010) Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrob Agents Chemother 54(6):2655-9
CGD Papers Entry Pubmed Entry Reference LINKOUT
C. albicans |GSC1 |GSC1 |GSL2 |GSL2
C. glabrata |FKS1



AltStyle によって変換されたページ (->オリジナル) /